Alloplex Biotherapeutics logo

Alloplex Biotherapeutics

Cambridge, MA

Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor types and is particularly suited to combinations with checkpoint inhibitors. Alloplex is a private company and currently supported by angel investment

alloplexbio.com

Company Details

Founded

2016

Employees

Between 5 - 10 employees

Raised

$21,200,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Frank BorrielloFrank Borriello

Founders

Frank Borriello
Frank Borriello

Company Collections

These are collections Alloplex Biotherapeutics is a part of. Click on the collection name to view similar companies.

Alloplex Biotherapeutics' Industries

Alloplex Biotherapeutics' Tech Stack

Alloplex Biotherapeutics Headquarters Location

21 Erie Street, Cambridge, MA 02139

Total Amount Raised: $21,200,000

Alloplex Biotherapeutics Funding Rounds

  • Series A

    $20,000,000

  • Corporate Round

    $1,000,000

    Corporate Round Investors

    Daewoong Pharmaceutical
    Hanall Biopharma Co.

  • Seed

    $200,000

Funding info provided by Diffbot.

Alloplex Biotherapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Alloplex Biotherapeutics.

Recent reviews